Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Revolution Medicines, Inc. - Common Stock (NQ: RVMD )

41.25 -0.09 (-0.22%)
Streaming Delayed Price Updated: 11:58 AM EST, Feb 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Revolution Medicines, Inc. - Common Stock

< Previous 1 2 3 4 Next >
Microsoft To Rally Around 6%? Here Are 10 Top Analyst Forecasts For Tuesday
Via Benzinga
Why Helen of Troy Shares Are Trading Lower By Around 30%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Nvidia, Micron, Arlo Technologies And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Revolution Medicines Inc. (NASDAQ: RVMD) Climbs to New 52-Week High
Via Investor Brand Network
Revolution Medicines's Earnings: A Preview
Via Benzinga
What 6 Analyst Ratings Have To Say About Revolution Medicines
Via Benzinga
Earnings Scheduled For February 26, 2025
Via Benzinga
Top 3 Health Care Stocks That Could Blast Off In December
Via Benzinga
Dow Dips 150 Points; ISM Manufacturing PMI Tops Estimates
Via Benzinga
Topics Stocks
Exposures US Equities
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Stellantis, PG&E And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
Top 3 Health Care Stocks That Should Keep You Up At Night This Quarter
Via Benzinga
Earnings Scheduled For November 6, 2023
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million. 
Via Benzinga
Preview: Revolution Medicines's Earnings
Via Benzinga
The 7 Most Undervalued Under-$50 Stocks to Buy in June 2024
Undervalued stocks under $50 hold significant appeal, but as every investor knows, value is in the eye of the beholder 
Via InvestorPlace
The 3 Most Undervalued Biotech Stocks to Buy in June 2024
https://seekingalpha.com/news/4111624-goldman-sachs-raises-obesity-drug-market-estimate 
Via InvestorPlace
RVMD Stock Earnings: Revolution Medicines Beats EPS for Q1 2024
RVMD stock results show that Revolution Medicines beat analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
Top 3 Health Care Stocks That May Collapse In Q2
As of April 12, 2024, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. 
Via Benzinga
Why Ascent Solar Technologies Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Ascent Solar Technologies, Inc. (NASDAQ: ASTI) fell sharply during Wednesday’s session after the company announced pricing of a $6 million public offering of shares at $0.14 per share. 
Via Benzinga
What's Going On With Revolution Medicines Stock?
Revolution Medicines announced the publication of a peer-reviewed research paper in "Cancer Discovery" detailing the discovery and preclinical to clinical translation for RMC-6236 on Monday. The... 
Via Benzinga
Roblox, TAL Education And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were lower, with the Dow Jones index falling over 300 points on Wednesday. 
Via Benzinga
Topics Stocks
Exposures US Equities
Morgan Stanley Maintains Equal-Weight Rating for Revolution Medicines: Here's What You Need To Know
Via Benzinga
Uncovering Noteworthy Technical Analysis Findings for REVOLUTION MEDICINES INC (NASDAQ:RVMD).
A technical analysis of REVOLUTION MEDICINES INC. 
Via Chartmill
Pharma’s Frontline: 3 Stocks Driving Revolutionary Drug Development
These pharma stock leaders offer revolutionary treatments that could change the world of medicine (and investor's portfolios) for the better. 
Via InvestorPlace
Earnings Scheduled For February 26, 2024
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.23 per share on revenue of $477.73 million. 
Via Benzinga
3 Biotech Stocks That Could Boom or Bust by 2025
Biotech stocks are popular with investors because they sometimes provide tremendous rewards. Here are three to buy for a potential payday. 
Via InvestorPlace
Cancer Player Revolution Medicines Gets Bullish Rating: Here's Details
Raymond James initiated coverage on Revolution Medicines Inc (NASDAQ: RVMD), noting that the October readout of RMC-6236 was compelling compared to historical SoC. 
Via Benzinga
Crude Oil Falls Sharply; Apollomics Shares Plunge
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite gaining over 100 points on Monday. The Dow traded down 0.19% to 33,062.85 while the NASDAQ rose 0.80% to 13,088.09. The S&P... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Why EngageSmart Shares Are Trading Higher By Around 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers INVO Bioscience, Inc. (NASDAQ: INVO) jumped 375% to $2.57 as the company agreed to acquire NAYA Biosciences in an all-stock transaction. 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.